{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:26:57Z","timestamp":1793471217297,"version":"4.5.0"},"reference-count":130,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["TMCG-3_213736"],"award-info":[{"award-number":["TMCG-3_213736"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["519224235"],"award-info":[{"award-number":["519224235"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022716","name":"Swiss Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022716","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013850","name":"Helmut Horten Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["113-2314-B-002 -087 -MY3"],"award-info":[{"award-number":["113-2314-B-002 -087 -MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cancer"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.trecan.2025.04.008","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T11:17:47Z","timestamp":1746789467000},"page":"676-690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Tumor-draining lymph nodes \u2013 friend or foe during immune checkpoint therapy?"],"prefix":"10.1016","volume":"11","author":[{"given":"Janusz","family":"von Renesse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Chun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3078-3774","authenticated-orcid":false,"given":"Ping-Chih","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trecan.2025.04.008_bb0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-cellbio-100913-013254","article-title":"Spatiotemporal basis of innate and adaptive immunity in secondary lymphoid tissue","volume":"30","author":"Qi","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0010","doi-asserted-by":"crossref","first-page":"8065","DOI":"10.1158\/0008-5472.CAN-06-1392","article-title":"Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications","volume":"66","author":"Hoshida","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2025.04.008_bb0015","doi-asserted-by":"crossref","first-page":"7828","DOI":"10.1158\/0008-5472.CAN-08-1488","article-title":"Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis","volume":"68","author":"Burton","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2025.04.008_bb0020","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jnci\/94.11.819","article-title":"Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling","volume":"94","author":"He","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.trecan.2025.04.008_bb0025","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1038\/s41467-022-31941-w","article-title":"Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC","volume":"13","author":"Saddawi-Konefka","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.04.008_bb0030","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.1038\/s41467-022-34676-w","article-title":"Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors","volume":"13","author":"Darragh","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.04.008_bb0035","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ccell.2020.09.001","article-title":"The PD-1\/PD-L1-checkpoint restrains T cell immunity in tumor-draining lymph nodes","volume":"38","author":"Dammeijer","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2025.04.008_bb0040","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1016\/j.cell.2022.09.020","article-title":"The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1\/PD-L1 blockade in draining lymph nodes","volume":"185","author":"Huang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2025.04.008_bb0045","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124507","article-title":"Tumor-draining lymph nodes are pivotal in PD-1\/PD-L1 checkpoint therapy","volume":"3","author":"Fransen","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.trecan.2025.04.008_bb0050","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41577-020-0281-x","article-title":"Lymphatic endothelial cells of the lymph node","volume":"20","author":"Jalkanen","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0055","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/ni.2889","article-title":"The atypical chemokine receptor CCRL1 shapes functional CCL21 gradients in lymph nodes","volume":"15","author":"Ulvmar","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0060","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.immuni.2019.04.002","article-title":"Lymphatic endothelial cells are essential components of the subcapsular sinus macrophage niche","volume":"50","author":"Mondor","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.trecan.2025.04.008_bb0065","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1038\/ncomms7771","article-title":"Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction","volume":"6","author":"Rouhani","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.04.008_bb0070","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1182\/blood-2012-04-427013","article-title":"Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells","volume":"120","author":"Tewalt","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2025.04.008_bb0075","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41467-019-14127-9","article-title":"Lymphatic endothelial cells prime na\u00efve CD8+ T cells into memory cells under steady-state conditions","volume":"11","author":"Vokali","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.04.008_bb0080","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1096\/fj.12-205278","article-title":"Lymph node-derived lymphatic endothelial cells express functional costimulatory molecules and impair dendritic cell-induced allogenic T-cell proliferation","volume":"26","author":"N\u00f6rder","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.trecan.2025.04.008_bb0085","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10456-021-09792-8","article-title":"High endothelial venules (HEVs) in immunity, inflammation and cancer","volume":"24","author":"Blanchard","year":"2021","journal-title":"Angiogenesis"},{"key":"10.1016\/j.trecan.2025.04.008_bb0090","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.4049\/jimmunol.171.4.1642","article-title":"Cutting edge: the B cell chemokine CXC chemokine ligand 13\/B lymphocyte chemoattractant is expressed in the high endothelial venules of lymph nodes and Peyer\u2019s patches and affects B cell trafficking across high endothelial venules","volume":"171","author":"Ebisuno","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0095","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1073\/pnas.95.1.258","article-title":"A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes","volume":"95","author":"Gunn","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2025.04.008_bb0100","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1084\/jem.193.9.1105","article-title":"The CCR7 ligand elc (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment","volume":"193","author":"Baekkevold","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.trecan.2025.04.008_bb0105","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.it.2021.07.003","article-title":"Communication, construction, and fluid control: lymphoid organ fibroblastic reticular cell and conduit networks","volume":"42","author":"Acton","year":"2021","journal-title":"Trends Immunol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0110","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/s41590-023-01503-3","article-title":"Conserved stromal\u2013immune cell circuits secure B cell homeostasis and function","volume":"24","author":"L\u00fctge","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0115","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.4049\/jimmunol.1402520","article-title":"Fibroblastic reticular cells: organization and regulation of the T lymphocyte life cycle","volume":"194","author":"Brown","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0120","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.coi.2020.04.007","article-title":"The fibroblastic T cell niche in lymphoid tissues","volume":"64","author":"Fletcher","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0125","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ni.3035","article-title":"The CLEC-2\u2013podoplanin axis controls the contractility of fibroblastic reticular cells and lymph node microarchitecture","volume":"16","author":"Astarita","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ni1427","article-title":"Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self","volume":"8","author":"Lee","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0135","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1084\/jem.20132000","article-title":"Lymph node stromal cells acquire peptide\u2013MHCII complexes from dendritic cells and induce antigen-specific CD4+ T cell tolerance","volume":"211","author":"Dubrot","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.trecan.2025.04.008_bb0140","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trecan.2025.04.008_bb0145","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature10540","article-title":"Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules","volume":"479","author":"Moussion","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.04.008_bb0150","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.trecan.2018.09.001","article-title":"The role of type 1 conventional dendritic cells in cancer immunity","volume":"4","author":"B\u00f6ttcher","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.trecan.2025.04.008_bb0155","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ccell.2016.06.003","article-title":"Critical role for CD103+\/CD141+ dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma","volume":"30","author":"Roberts","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2025.04.008_bb0160","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ccell.2014.09.007","article-title":"Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity","volume":"26","author":"Broz","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2025.04.008_bb0165","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav7431","article-title":"Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy","volume":"12","author":"Mayoux","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.trecan.2025.04.008_bb0170","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41590-018-0290-0","article-title":"Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycle","volume":"20","author":"Cheng","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0175","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1159\/000337007","article-title":"Lymph node macrophages. J","volume":"4","author":"Gray","year":"2012","journal-title":"Innate Immun."},{"key":"10.1016\/j.trecan.2025.04.008_bb0180","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.immuni.2010.12.011","article-title":"CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens","volume":"34","author":"Asano","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.trecan.2025.04.008_bb0185","article-title":"Sinusoidal immunity: macrophages at the lymphohematopoietic interface","volume":"7","author":"Gordon","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0190","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg3551","article-title":"Tumor-draining lymph nodes: at the crossroads of metastasis and immunity","volume":"6","author":"du Bois","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0195","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nri2974","article-title":"The outs and the ins of sphingosine-1-phosphate in immunity","volume":"11","author":"Spiegel","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0200","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.immuni.2021.08.026","article-title":"Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1+ CD8+ T cells in tumor-draining lymph nodes","volume":"54","author":"Schenkel","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.trecan.2025.04.008_bb0205","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg7836","article-title":"A reservoir of stem-like CD8+ T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response","volume":"6","author":"Connolly","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0210","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1007\/s00262-021-02934-3","article-title":"Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used","volume":"70","author":"Fear","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.trecan.2025.04.008_bb0215","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2353\/ajpath.2007.060761","article-title":"Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis","volume":"170","author":"Harrell","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0220","first-page":"1387","article-title":"Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism","volume":"2","author":"Garc\u00eda-Silva","year":"2021","journal-title":"Nat. Can."},{"key":"10.1016\/j.trecan.2025.04.008_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12197","article-title":"Melanoma-derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes","volume":"11","author":"Leary","year":"2022","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.trecan.2025.04.008_bb0230","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.cell.2022.04.019","article-title":"Lymph node colonization induces tumor-immune tolerance to promote distant metastasis","volume":"185","author":"Reticker-Flynn","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2025.04.008_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110447","article-title":"Tumor-educated T(regs) drive organ-specific metastasis in breast cancer by impairing NK cells in the lymph node niche","volume":"38","author":"Kos","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.trecan.2025.04.008_bb0240","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/s41551-021-00766-1","article-title":"Solid stress impairs lymphocyte infiltration into lymph-node metastases","volume":"5","author":"Jones","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.trecan.2025.04.008_bb0245","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ni.3492","article-title":"Tumor-induced stromal reprogramming drives lymph node transformation","volume":"17","author":"Riedel","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0250","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10585-013-9610-9","article-title":"Pre-treatment of mice with tumor-conditioned media accelerates metastasis to lymph nodes and lungs: a new spontaneous breast cancer metastasis model","volume":"31","author":"Lee","year":"2014","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.trecan.2025.04.008_bb0255","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1158\/0008-5472.CAN-06-4494","article-title":"Extralymphatic tumors prepare draining lymph nodes to invasion via a T-cell cross-tolerance process","volume":"67","author":"Preynat-Seauve","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2025.04.008_bb0260","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/84643","article-title":"Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis","volume":"7","author":"Skobe","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.trecan.2025.04.008_bb0265","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41467-017-00504-9","article-title":"Interactions between fibroblastic reticular cells and B cells promote mesenteric lymph node lymphangiogenesis","volume":"8","author":"Dubey","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.04.008_bb0270","doi-asserted-by":"crossref","first-page":"10365","DOI":"10.1158\/0008-5472.CAN-06-2977","article-title":"Preparing the \u2018soil\u2019: the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells","volume":"66","author":"Qian","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2025.04.008_bb0275","doi-asserted-by":"crossref","DOI":"10.1093\/emboj\/20.4.672","article-title":"Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis","volume":"20","author":"Mandriota","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.trecan.2025.04.008_bb0280","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0002-9440(10)64328-3","article-title":"Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival","volume":"162","author":"Dadras","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0285","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1158\/1078-0432.CCR-03-0195","article-title":"CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells","volume":"10","author":"Takeuchi","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2025.04.008_bb0290","doi-asserted-by":"crossref","first-page":"9042","DOI":"10.1073\/pnas.1219603110","article-title":"PI3K\u03b1 activates integrin \u03b14\u03b21 to establish a metastatic niche in lymph nodes","volume":"110","author":"Garmy-Susini","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.trecan.2025.04.008_bb0295","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1158\/0008-5472.CAN-09-3761","article-title":"Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis","volume":"70","author":"Garmy-Susini","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2025.04.008_bb0300","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ccell.2023.02.002","article-title":"High endothelial venules in cancer: regulation, function, and therapeutic implication","volume":"41","author":"Vella","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2025.04.008_bb0305","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4161\/cbt.27328","article-title":"Alterations of high endothelial venules in primary and metastatic tumors are correlated with lymph node metastasis of oral and pharyngeal carcinoma","volume":"15","author":"Shen","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.trecan.2025.04.008_bb0310","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1016\/j.celrep.2019.02.042","article-title":"Single-cell analysis reveals heterogeneity of high endothelial venules and different regulation of genes controlling lymphocyte entry to lymph nodes","volume":"26","author":"Veerman","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.trecan.2025.04.008_bb0315","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1038\/s41467-020-17291-5","article-title":"A molecular map of murine lymph node blood vascular endothelium at single cell resolution","volume":"11","author":"Brulois","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.04.008_bb0320","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.trecan.2020.10.001","article-title":"The dual role of high endothelial venules in cancer progression versus immunity","volume":"7","author":"Milutinovic","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.trecan.2025.04.008_bb0325","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1158\/2326-6066.CIR-17-0131","article-title":"Treg depletion licenses T cell-driven HEV neogenesis and promotes tumor destruction","volume":"5","author":"Colbeck","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.trecan.2025.04.008_bb0330","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1097\/TP.0000000000002774","article-title":"Differential regulation of T-cell immunity and tolerance by stromal laminin expressed in the lymph node","volume":"103","author":"Simon","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.trecan.2025.04.008_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13020211","article-title":"Remodeling of the lymph node high endothelial venules reflects tumor invasiveness in breast cancer and is associated with dysregulation of perivascular stromal cells","volume":"13","author":"Bekkhus","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.trecan.2025.04.008_bb0340","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1158\/2326-6066.CIR-21-0778","article-title":"Tumor-derived lactic acid modulates activation and metabolic status of draining lymph node stroma","volume":"10","author":"Riedel","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.trecan.2025.04.008_bb0345","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1158\/1078-0432.CCR-10-1073","article-title":"Accumulation of Foxp3+ T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patients","volume":"16","author":"Deng","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2025.04.008_bb0350","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1038\/s41467-020-17046-2","article-title":"Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients","volume":"11","author":"N\u00fa\u00f1ez","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.04.008_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101469","article-title":"Tumour-draining lymph nodes in head and neck cancer are characterized by accumulation of CTLA-4 and PD-1 expressing Treg cells","volume":"23","author":"Piersiala","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0360","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1038\/s41467-018-04524-x","article-title":"Induction of anergic or regulatory tumor-specific CD4+ T cells in the tumor-draining lymph node","volume":"9","author":"Alonso","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.04.008_bb0365","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2404916121","article-title":"Peripheral-derived regulatory T cells contribute to tumor-mediated immune suppression in a nonredundant manner","volume":"121","author":"Hossain","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.trecan.2025.04.008_bb0370","doi-asserted-by":"crossref","first-page":"12341","DOI":"10.1002\/jev2.12341","article-title":"Tumour extracellular vesicles induce neutrophil extracellular traps to promote lymph node metastasis","volume":"12","author":"Su","year":"2023","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.trecan.2025.04.008_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111171","article-title":"During early stages of cancer, neutrophils initiate anti-tumor immune responses in tumor-draining lymph nodes","volume":"40","author":"Pylaeva","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.trecan.2025.04.008_bb0380","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1038\/s41416-024-02891-5","article-title":"Phenotypical differences of neutrophils patrolling tumour-draining lymph nodes in head and neck cancer","volume":"131","author":"Ekstedt","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.trecan.2025.04.008_bb0385","doi-asserted-by":"crossref","first-page":"P65","DOI":"10.1186\/2051-1426-3-S2-P65","article-title":"B cells in tumor draining lymph nodes act as efficient antigen presenting cells in cancer patients","volume":"3","author":"Zirakzadeh","year":"2015","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.trecan.2025.04.008_bb0390","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41591-018-0309-y","article-title":"Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG","volume":"25","author":"Gu","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.trecan.2025.04.008_bb0395","first-page":"3779","article-title":"Mechanisms and characteristics of subcapsular sinus macrophages in tumor immunity: a narrative review. Transl","volume":"12","author":"Su","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2025.04.008_bb0400","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/0194599819829741","article-title":"Loss of CD169+ subcapsular macrophages during metastatic spread of head and neck squamous cell carcinoma","volume":"161","author":"Topf","year":"2019","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.trecan.2025.04.008_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108993","article-title":"CD169+ lymph node macrophages have protective functions in mouse breast cancer metastasis","volume":"35","author":"Tacconi","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.trecan.2025.04.008_bb0410","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.aaf1328","article-title":"SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions","volume":"352","author":"Pucci","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.trecan.2025.04.008_bb0415","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.omtn.2019.04.016","article-title":"Targeting lymph node sinus macrophages to inhibit lymph node metastasis","volume":"16","author":"Hu","year":"2019","journal-title":"Mol. Ther. Nucl. Acids"},{"key":"10.1016\/j.trecan.2025.04.008_bb0420","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1158\/2326-6066.CIR-22-0225","article-title":"Subcapsular sinus macrophages promote melanoma metastasis to the sentinel lymph nodes via an IL1\u03b1-STAT3 axis","volume":"10","author":"Virgilio","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.trecan.2025.04.008_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2025.02.017","article-title":"Lymph node macrophages drive immune tolerance and resistance to cancer therapy by induction of the immune-regulatory cytokine IL-33","author":"Lamorte","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2025.04.008_bb0430","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.4049\/jimmunol.181.5.3291","article-title":"Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes","volume":"181","author":"Watanabe","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2021.104296","article-title":"Monocytic myeloid-derived suppressor cells home to tumor-draining lymph nodes via CCR2 and locally modulate the immune response","volume":"362","author":"Lahmar","year":"2021","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0440","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.17375","article-title":"Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes","volume":"5","author":"Ku","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.trecan.2025.04.008_bb0445","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","article-title":"Involvement of chemokine receptors in breast cancer metastasis","volume":"410","author":"M\u00fcller","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.04.008_bb0450","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1158\/0008-5472.CAN-08-1875","article-title":"Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell\u2013lymphatic cross-talk promote invasive phenotype","volume":"69","author":"Issa","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2025.04.008_bb0455","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41586-020-2623-z","article-title":"Lymph protects metastasizing melanoma cells from ferroptosis","volume":"585","author":"Ubellacker","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.04.008_bb0460","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s40425-019-0605-1","article-title":"Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node","volume":"7","author":"van Pul","year":"2019","journal-title":"J. ImmunoTher. Cancer"},{"key":"10.1016\/j.trecan.2025.04.008_bb0465","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.cell.2023.02.021","article-title":"Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes","volume":"186","author":"Rahim","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2025.04.008_bb0470","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.immuni.2022.12.002","article-title":"CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor","volume":"56","author":"Prokhnevska","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.trecan.2025.04.008_bb0475","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41577-019-0223-7","article-title":"Precursor exhausted T cells: key to successful immunotherapy?","volume":"20","author":"Kallies","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0480","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0485","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1+PD-1+CD8+ T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.trecan.2025.04.008_bb0490","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-019-1836-5","article-title":"An intra-tumoral niche maintains and differentiates stem-like CD8 T cells","volume":"576","author":"Jansen","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.04.008_bb0495","first-page":"108","article-title":"Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer","volume":"3","author":"Liu","year":"2022","journal-title":"Nat. Can."},{"key":"10.1016\/j.trecan.2025.04.008_bb0500","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","article-title":"Clonal replacement of tumor-specific T cells following PD-1 blockade","volume":"25","author":"Yost","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.trecan.2025.04.008_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2022.06.018","article-title":"Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy","volume":"185","author":"Luoma","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2025.04.008_bb0510","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cell.2016.12.022","article-title":"Systemic immunity is required for effective cancer immunotherapy","volume":"168","author":"Spitzer","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2025.04.008_bb0515","doi-asserted-by":"crossref","first-page":"7695","DOI":"10.1038\/s41467-024-52098-8","article-title":"Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study","volume":"15","author":"Eerkens","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.04.008_bb0520","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00262-020-02792-5","article-title":"Tumor-draining lymph nodes are survival niches that support T cell priming against lymphatic transported tumor antigen and effects of immune checkpoint blockade in TNBC","volume":"70","author":"O\u2019Melia","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.trecan.2025.04.008_bb0525","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41586-020-2056-8","article-title":"Peripheral T cell expansion predicts tumour infiltration and clinical response","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.04.008_bb0530","doi-asserted-by":"crossref","first-page":"9401","DOI":"10.3390\/ijms22179401","article-title":"Immune checkpoint therapy: tumor draining lymph nodes in the spotlights","volume":"22","author":"Fransen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trecan.2025.04.008_bb0535","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trecan.2025.04.008_bb0540","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0545","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.trecan.2025.04.008_bb0550","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1200\/JCO.20.03637","article-title":"Neck dissections based on sentinel lymph node navigation versus elective neck dissections in early oral cancers: a randomized, multicenter, and noninferiority trial","volume":"39","author":"Hasegawa","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0555","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","article-title":"Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial","volume":"17","author":"Leiter","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0560","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.annonc.2023.01.004","article-title":"Survival update of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma in the OpACIN and OpACIN-neo trials","volume":"34","author":"Versluis","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0565","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1056\/NEJMoa2211437","article-title":"Neoadjuvant\u2013adjuvant or adjuvant-only pembrolizumab in advanced melanoma","volume":"388","author":"Patel Sapna","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trecan.2025.04.008_bb0570","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1158\/1078-0432.CCR-21-3351","article-title":"Phase II clinical trial of neoadjuvant and adjuvant pembrolizumab in resectable local\u2013regionally advanced head and neck squamous cell carcinoma","volume":"28","author":"Wise-Draper","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2025.04.008_bb0575","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002485","article-title":"Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma","volume":"9","author":"Leidner","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.trecan.2025.04.008_bb0580","article-title":"Cancer immunotherapy responses persist after lymph node resection [preprint]","author":"Zhou","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.trecan.2025.04.008_bb0585","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.ccell.2022.06.009","article-title":"Immune suppression in the tumor-draining lymph node corresponds with distant disease recurrence in patients with melanoma","volume":"40","author":"van Krimpen","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2025.04.008_bb0590","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1200\/JCO.2003.04.042","article-title":"Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8+ T-cell function in melanoma patients","volume":"21","author":"Bedrosian","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.trecan.2025.04.008_bb0595","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/s41563-020-0680-1","article-title":"Metabolic labeling and targeted modulation of dendritic cells","volume":"19","author":"Wang","year":"2020","journal-title":"Nat. Mater."},{"key":"10.1016\/j.trecan.2025.04.008_bb0600","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay3575","article-title":"Blockade of immune checkpoints in lymph nodes through locoregional delivery augments cancer immunotherapy","volume":"12","author":"Francis","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.trecan.2025.04.008_bb0605","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.146608","article-title":"Coimmunomodulation of tumor and tumor-draining lymph nodes during in situ vaccination promotes antitumor immunity","volume":"7","author":"Jeong","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.trecan.2025.04.008_bb0610","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1182\/blood-2009-02-206870","article-title":"Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment","volume":"114","author":"Lee","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.trecan.2025.04.008_bb0615","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00262-024-03754-x","article-title":"High expression of PD-L1 on conventional dendritic cells in tumour-draining lymph nodes is associated with poor prognosis in oral cancer","volume":"73","author":"Eric","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.trecan.2025.04.008_bb0620","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41591-020-01188-3","article-title":"Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)","volume":"27","author":"Menzies","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.trecan.2025.04.008_bb0625","first-page":"176","article-title":"Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer","volume":"1","author":"Moding","year":"2020","journal-title":"Nat. Can."},{"key":"10.1016\/j.trecan.2025.04.008_bb0630","doi-asserted-by":"crossref","first-page":"6909","DOI":"10.1158\/1078-0432.CCR-18-2688","article-title":"Use of circulating tumor DNA for cancer immunotherapy","volume":"25","author":"Snyder","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2025.04.008_bb0635","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1158\/2326-6066.CIR-19-0398","article-title":"TCR repertoire diversity of peripheral PD-1(+)CD8(+) T cells predicts clinical outcomes after immunotherapy in patients with non-small cell lung cancer","volume":"8","author":"Han","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.trecan.2025.04.008_bb0640","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072378","article-title":"Molecular T-cell repertoire analysis as source of prognostic and predictive biomarkers for checkpoint blockade immunotherapy","volume":"21","author":"Aversa","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trecan.2025.04.008_bb0645","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132286","article-title":"Multipanel mass cytometry reveals anti-PD-1 therapy-mediated B and T cell compartment remodeling in tumor-draining lymph nodes","volume":"5","author":"Ho","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.trecan.2025.04.008_bb0650","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1038\/s41590-024-01999-3","article-title":"Dysfunction of exhausted T cells is enforced by MCT11-mediated lactate metabolism","volume":"25","author":"Peralta","year":"2024","journal-title":"Nat. Immunol."}],"container-title":["Trends in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803325001049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803325001049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:55:09Z","timestamp":1778882109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405803325001049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":130,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2405803325001049"],"URL":"https:\/\/doi.org\/10.1016\/j.trecan.2025.04.008","relation":{},"ISSN":["2405-8033"],"issn-type":[{"value":"2405-8033","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-draining lymph nodes \u2013 friend or foe during immune checkpoint therapy?","name":"articletitle","label":"Article Title"},{"value":"Trends in Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trecan.2025.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}